Bank OZK’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Hold |
3,972
| – | – | 0.13% | 117 |
|
|
2025
Q1 | $322K | Hold |
3,972
| – | – | 0.13% | 115 |
|
|
2024
Q4 | $358K | Sell |
3,972
-244
| -6% | -$22K | 0.15% | 110 |
|
|
2024
Q3 | $417K | Buy |
4,216
+52
| +1% | +$5.14K | 0.17% | 105 |
|
|
2024
Q2 | $386K | Buy |
4,164
+85
| +2% | +$7.88K | 0.17% | 109 |
|
|
2024
Q1 | $387K | Sell |
4,079
-28
| -0.7% | -$2.66K | 0.17% | 109 |
|
|
2023
Q4 | $367K | Sell |
4,107
-2,345
| -36% | -$209K | 0.18% | 112 |
|
|
2023
Q3 | $471K | Sell |
6,452
-407
| -6% | -$29.7K | 0.26% | 98 |
|
|
2023
Q2 | $571K | Sell |
6,859
-53
| -0.8% | -$4.41K | 0.27% | 92 |
|
|
2023
Q1 | $527K | Hold |
6,912
| – | – | 0.26% | 82 |
|
|
2022
Q4 | $574K | Buy |
6,912
+2,855
| +70% | +$237K | 0.28% | 82 |
|
|
2022
Q3 | $322K | Buy |
+4,057
| New | +$322K | 0.17% | 100 |
|
|
2022
Q2 | – | Sell |
-2,480
| Closed | -$223K | – | 126 |
|
|
2022
Q1 | $223K | Buy |
2,480
+179
| +8% | +$16.1K | 0.1% | 119 |
|
|
2021
Q4 | $258K | Buy |
+2,301
| New | +$258K | 0.11% | 115 |
|
|
2019
Q4 | – | Sell |
-10,250
| Closed | -$781K | – | 135 |
|
|
2019
Q3 | $781K | Buy |
10,250
+605
| +6% | +$46.1K | 0.34% | 66 |
|
|
2019
Q2 | $846K | Buy |
9,645
+2,155
| +29% | +$189K | 0.37% | 62 |
|
|
2019
Q1 | $678K | Buy |
7,490
+330
| +5% | +$29.9K | 0.3% | 75 |
|
|
2018
Q4 | $514K | Buy |
7,160
+3,265
| +84% | +$234K | 0.26% | 82 |
|
|
2018
Q3 | $373K | Buy |
3,895
+50
| +1% | +$4.79K | 0.15% | 105 |
|
|
2018
Q2 | $366K | Buy |
+3,845
| New | +$366K | 0.14% | 104 |
|